Release time：2023-10-12
On the afternoon of September 5th, Zhu Zhengqing, vice chairman of Changzhou CPPCC and director of the Management Committee of Science and Education City, and Fan Junjun, member of the Party Working Committee of Changzhou Science and Education City and director of Changzhou National University Science and Technology Park Management Center, visited our company for investigation and inspection, and Chen Qiaoling, general manager of the company, accompanied the reception throughout the process.
General Manager Chen Qiaoling introduced the background of the establishment of the company, the distribution of talent teams, the R&D progress and the product market planning to Director Zhu and Director Fan in detail. And the company's core technology modules (microfluidic chip, biosensing chip, reagent, multi-channel portable gene rapid detector) prototype were displayed. Through the prototype demonstration, the leaders intuitively understood the automatic operation process of genetic testing.
The LAMP-BIOSENSOR-AI rapid genetic screening technology pioneered by Xianjing Medical can achieve accurate, rapid and convenient genetic screening, and its application fields are widely used in medicine, food, pets, animal epidemic prevention, environmental testing, etc. The company's cutting-edge technology and broad application prospects were highly affirmed and praised by Director Zhu, and the hospital and other corporate resources were recommended to the company on the spot. He said that through this investigation and inspection, he understood the company's current business situation, had a deeper understanding of the company's product characteristics and innovative technologies, and hoped that the company would strengthen cooperation with the outside world, accelerate research and development progress, and put into production as soon as possible.
